Poster
03-16-2005, 01:05 PM
Up to 145 clinical pharmacists at the CMS will begin a month longer review of formularies for private plans offering coverage under the new Medicare prescription drug benefit. USP specified that the private drug plans should offer at least two drugs in each category under Medicare. Also Medicare officials should require insurers to justify any exclusion of subclasses by providing substantial clinical, scientific or other rationale.
“Babette Edgar, head of the CMS Medicare Drug Benefit Group's operations division, on Monday at a forum on formularies sponsored by the Kaiser Family Foundation said that formulary reviewers next month plan to ensure prescription drug plans cover "substantially all, if not all," drugs in certain categories, including HIV/AIDS drugs, according to CQ HealthBeat.”
“However, an unnamed HIV advocate at the forum told Edgar that an HIV/AIDS-related drug could be covered by the plan and not be "accessible" if the plan's cost-sharing tiers required a high copayment for the drug, CQ HealthBeat reports.”
For more information see: http://www.medicalnewstoday.com/medicalnews.php?newsid=21292
“Babette Edgar, head of the CMS Medicare Drug Benefit Group's operations division, on Monday at a forum on formularies sponsored by the Kaiser Family Foundation said that formulary reviewers next month plan to ensure prescription drug plans cover "substantially all, if not all," drugs in certain categories, including HIV/AIDS drugs, according to CQ HealthBeat.”
“However, an unnamed HIV advocate at the forum told Edgar that an HIV/AIDS-related drug could be covered by the plan and not be "accessible" if the plan's cost-sharing tiers required a high copayment for the drug, CQ HealthBeat reports.”
For more information see: http://www.medicalnewstoday.com/medicalnews.php?newsid=21292